Patients with International Prostate Symptom Score 8 , total prostatic volume ( TPV ) > 30 mL , and maximum flow rate ( Qmax ) < 15 mL/s were randomly assigned to the 5-reductase inhibitor ( 5ARI ) discontinue ( DC-5ARI ) or - blocker discontinue ( DC -- blocker ) group .